Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

111.26
Delayed Data
As of Jul 28
 +3.15 / +2.91%
Today’s Change
92.98
Today|||52-Week Range
136.40
-7.10%
Year-to-Date
Celgene's Otezla Is A Big Hit
Jul 28 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene
Jul 28 / Zacks.com - Paid Partner Content
This Small Gain Is a Big Win for Celgene Corporation
Jul 28 / MotleyFool.com - Paid Partner Content
Pre-Market Activity Shows Gains For Celgene (CELG)
Jul 28 / TheStreet.com - Paid Partner Content
Hep C Business Slow-Down Could Hamper Bristol-Myers' Future
Jul 28 / TheStreet.com - Paid Partner Content
Celgene (CELG) Beats on Q2 Earnings and Revenues
Jul 28 / Zacks.com - Paid Partner Content
Celgene (CELG) Tops Q2 Earnings & Revenues, Lifts View
Jul 28 / Zacks.com - Paid Partner Content
Celgene 2Q Earnings Yield No Surprises, Small Guidance Bump
Jul 28 / TheStreet.com - Paid Partner Content
3 Stocks That Could Double Your Money
Jul 28 / MotleyFool.com - Paid Partner Content
Celgene (CELG) Stock Climbs on Q2 Earnings, Revenue Beat
Jul 28 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close108.11
Today’s open109.91
Day’s range109.80 - 112.25
Volume8,339,155
Average volume (3 months)4,514,222
Market cap$83.7B
Dividend yield--
Data as of 3:59pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+21.07%
Earnings growth (next 5 years)+23.20%
Revenue growth (last year)+16.47%
P/E ratio54.1
Price/Sales11.10
Price/Book14.37

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+2.75+8.72%
LLYEli Lilly and Co-0.47-0.56%
AGNAllergan-4.68-1.80%
ABTAbbott Laboratories+0.78+1.79%
Data as of 4:03pm ET, 07/28/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.39
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers

Search for Jobs